US Bancorp’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $519K | Buy |
14,418
+935
| +7% | +$33.7K | ﹤0.01% | 1480 |
|
|
2025
Q1 | $420K | Buy |
13,483
+3,918
| +41% | +$122K | ﹤0.01% | 1584 |
|
|
2024
Q4 | $244K | Buy |
9,565
+5,759
| +151% | +$147K | ﹤0.01% | 1919 |
|
|
2024
Q3 | $108K | Sell |
3,806
-2,050
| -35% | -$58K | ﹤0.01% | 2361 |
|
|
2024
Q2 | $154K | Sell |
5,856
-3,527
| -38% | -$93K | ﹤0.01% | 2125 |
|
|
2024
Q1 | $285K | Buy |
9,383
+864
| +10% | +$26.2K | ﹤0.01% | 1824 |
|
|
2023
Q4 | $239K | Buy |
8,519
+4,759
| +127% | +$134K | ﹤0.01% | 1918 |
|
|
2023
Q3 | $102K | Buy |
3,760
+1,469
| +64% | +$39.9K | ﹤0.01% | 2136 |
|
|
2023
Q2 | $70.4K | Sell |
2,291
-3,248
| -59% | -$99.8K | ﹤0.01% | 2325 |
|
|
2023
Q1 | $200K | Buy |
5,539
+1,184
| +27% | +$42.7K | ﹤0.01% | 1864 |
|
|
2022
Q4 | $172K | Sell |
4,355
-626
| -13% | -$24.7K | ﹤0.01% | 1941 |
|
|
2022
Q3 | $201K | Sell |
4,981
-6,889
| -58% | -$278K | ﹤0.01% | 1847 |
|
|
2022
Q2 | $499K | Buy |
11,870
+765
| +7% | +$32.2K | ﹤0.01% | 1438 |
|
|
2022
Q1 | $433K | Buy |
11,105
+3,608
| +48% | +$141K | ﹤0.01% | 1592 |
|
|
2021
Q4 | $299K | Buy |
+7,497
| New | +$299K | ﹤0.01% | 1787 |
|
|
2021
Q3 | – | Sell |
-928
| Closed | -$38K | – | 4124 |
|
|
2021
Q2 | $38K | Buy |
928
+23
| +3% | +$942 | ﹤0.01% | 2793 |
|
|
2021
Q1 | $39K | Hold |
905
| – | – | ﹤0.01% | 2694 |
|
|
2020
Q4 | $45K | Hold |
905
| – | – | ﹤0.01% | 2546 |
|
|
2020
Q3 | $38K | Hold |
905
| – | – | ﹤0.01% | 2502 |
|
|
2020
Q2 | $44K | Buy |
+905
| New | +$44K | ﹤0.01% | 2436 |
|